News
Plano, Texas-based MediLynx, the US subsidiary of Poland's Medicalgorithmics, has received FDA 510(k) clearance for its PocketECG CRS Mobile Cardiac Rehabilitation System.
This morning, prescription digital therapeutic developer Click Therapeutics closed a $17 million funding round led by Sanofi Ventures, a subsidiary of pharma giant Sanofi.
Alexander Börve’s company FirstDerm offers online consultations with board-certified dermatologists and a free product that uses AI to give users ideas about what their skin condition might be.
Nearly two dozen chief information officers from leading U.S. health systems say they're keenly focused on patient engagement, a new report shows.
Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell.
The US Army’s medical division has been building a mobile technology platform that will streamline triage and communications in the event of medical evacuations, and is now looking for units to pilot the technology according to a recent release from the service’s public affairs division.
Healthcare organizations aren't making significant strides in adapting to consumerism, even despite increasing demand, competition for patient loyalty and plenty of lip service to the idea.
Health Wizz has updated and is piloting its unusual blockchain- and FHIR-enabled EHR aggregator mobile app, which uses blockchain to tokenize data, enabling patients to securely aggregate, organize, share, donate and/or trade their medical records.
InTouch cuts deal with Rite Aid, announces participation in newly formed World Telehealth Initiative
California-based telehealth provider InTouch Health inked a letter of intent alongside Rite Aid to explore how the virtual care platform can be implemented by the retail pharmacy chain to boost customers’ access to care.
The Department of Veterans Affairs and IBM Watson Health have announced a one-year extension to an ongoing public-private partnership applying the AI company’s technology to genomic data for cancer therapy.